Quarterly Result31 Jul 2025, 01:45 pm
Dr. Lal PathLabs Q1 FY26 Results: Revenue Up 11.3%, PAT Up 24.3%
AI Summary
Dr. Lal PathLabs Ltd, a leading diagnostic and related healthcare service provider, has announced its financial results for the quarter ended June 30, 2025. The company reported an 11.3% increase in revenue, a 13.1% increase in EBITDA with a margin of 28.7%, and a 24.3% increase in PAT with a margin of 20.0%. The company also declared an interim dividend of Rs. 6 per share for Q1 FY26. As on March 31, 2025, the company has 298 clinical laboratories, 6,607 Patient Service Centers, and 12,365 Pick-up Points.
Key Highlights
- Revenue increased by 11.3% in Q1 FY26
- EBITDA increased by 13.1% with a margin of 28.7%
- PAT increased by 24.3% with a margin of 20.0%
- Interim Dividend of Rs. 6 per share for Q1 FY26
- 298 clinical laboratories, 6,607 Patient Service Centers, and 12,365 Pick-up Points as on March 31, 2025